Comments on: Ceregene Awaits Parkinson’s Trial Results, In a Key Test for Gene Therapy http://www.xconomy.com/san-diego/2008/10/31/ceregene-awaits-parkinsons-trial-results-in-a-key-test-for-gene-therapy/ Business + Technology in the Exponential Economy Sat, 21 Nov 2009 22:30:41 -0600 http://wordpress.org/?v=2.8.6 hourly 1 By: Luke Timmerman http://www.xconomy.com/san-diego/2008/10/31/ceregene-awaits-parkinsons-trial-results-in-a-key-test-for-gene-therapy/comment-page-1/#comment-44409 Luke Timmerman Tue, 13 Jan 2009 19:46:48 +0000 http://www.xconomy.com/?p=5954#comment-44409 Irini, this study ended up failing, as I reported on Dec. 1. Here's a link to the follow-up. http://www.xconomy.com/san-diego/2008/12/01/ceregene-drug-fails-in-parkinsons-trial/ Irini, this study ended up failing, as I reported on Dec. 1. Here’s a link to the follow-up.

http://www.xconomy.com/san-diego/2008/12/01/ceregene-drug-fails-in-parkinsons-trial/

]]> By: Irini Kamperi http://www.xconomy.com/san-diego/2008/10/31/ceregene-awaits-parkinsons-trial-results-in-a-key-test-for-gene-therapy/comment-page-1/#comment-44408 Irini Kamperi Tue, 13 Jan 2009 19:33:49 +0000 http://www.xconomy.com/?p=5954#comment-44408 would like to be informed of develpments of the treatment begining in November of 2008 and if successful, dates of marketing expectations Thank you Irini Kamperi Akakion 53 Polydroso Amaroussiou 15125 Greece would like to be informed of
develpments of the treatment begining in November of 2008 and if
successful, dates of marketing expectations

Thank you
Irini Kamperi
Akakion 53
Polydroso Amaroussiou
15125
Greece

]]> By: Dr. J.A. Martinez http://www.xconomy.com/san-diego/2008/10/31/ceregene-awaits-parkinsons-trial-results-in-a-key-test-for-gene-therapy/comment-page-1/#comment-40675 Dr. J.A. Martinez Fri, 21 Nov 2008 04:44:29 +0000 http://www.xconomy.com/?p=5954#comment-40675 I would like to be informed of develpments of the treatment begining in November of 2008 and if successful, dates of marketing expectations I would like to be informed of
develpments of the treatment begining in November of 2008 and if
successful, dates of marketing expectations

]]>